(US) /    Tel: (781) 999-4286 / (781) 999-5354
Home > PARP
Cat.No. Product Name Information Area
T3917 Protopanaxatriol

Protopanaxatriol, a major ginseng constituent, is a novel PPARγ antagonist.

Metabolism system
T3231 Niraparib MK-4827(Niraparib) is a selective inhibitor of PARP1/PARP2 with IC50 of 3.8 nM/2.1 nM... Others
T3157 COH29 COH29 is an orally available, aromatically substituted thiazole and inhibitor of the ... Cancer
T3649 BGP-15 BGP-15 is a?PARP?inhibitor with protecting effect after ischemia-reperfusion injury.
T6942 Picolinamide Picolinamide is found to be a strong inhibitor of poly (ADP-ribose) synthetase of nuc... Others
T6912 NU1025 NU1025 is a potent PARP inhibitor with IC50 of 400 nM. Others
T6892 Niraparib tosylate MK-4827(Niraparib) tosylate (with IC50 of 3.8 nM/2.1 nM) is a selective PARP1/PARP2 i... Others
T6842 G007-LK G007-LK is a selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 nM and 25 nM, r... Others
T6780 Benzamide Benzamide, an inhibitor of poly(ADP-ribose) polymerase, is a derivative of benzoic ac... Others
T3375 Verbascosidenew Verbascoside is a protein kinase C inhibitor with antimicrobial, anti-inflammatory ac... Others
T3261 NVP-TNKS656 NVP-TNKS656 is a highly potent, selective, and orally active TNKS2 inhibitor.
T3197 Daprodustat Daprodustat (GSK1278863) is a HIF-prolyl hydroxylase inhibitor. Other
T3180 HIF-PHD Inhibitor II JNJ-42041935 is a potent (pKi = 7.3-7.9), 2-oxoglutarate competitive, reversible, and... Other
T3170 Troglitazone Troglitazone is a PPARγ agonist with anti-inflammatory and anti-tumor activity. Cancer
T3168 MN-64 MN-64 is a tankyrases inhibitor, showed 6 nM potency against tankyrase 1, isoenzyme s... Cancer
T1264 Ciprofibrate Ciprofibrate is a fibrate derivative with antilipidemic activity. Cardiovascular system
T6578 ME0328 ME0328 is a potent and selective PARP inhibitor with IC50 of 0.89 μM for PARP3, about... Cancer
T6366 A-966492 A-96649 is a new-type and effective inhibitor. The Ki of A-966492 for PARP1 and PARP2... Cancer
T6253 Talazoparib Talazoparib is a new-type PARP inhibitor (IC50: 0.58 nM), It similarly binds to PARP... Cancer
T6224 Iniparib Iniparib (BSI-201) ,a PARP1 inhibitor, exhibits potency in triple-negative breast Y (... Cancer
T6197 PJ34 PJ34 HCl is the hydrochloride salt of PJ34, which is a PARP inhibitor with EC50 of 20... Cancer
T6181 UPF 1069 UPF 1069 is a specific PARP2 inhibitor ( IC50: 0.3 μM). It is ~27-fold selective agai... Cancer
T6127 Rucaparib Phosphate Rucaparib is an inhibitor of PARP (Ki: 1.4 nM for PARP1) that is used in clinical the... Cancer
T3015 Olaparibhot Olaparib is a small molecule inhibitor of PARP1/PARP2 (IC50: 5/1 nM) but is less effe... Cancer
T2591 Veliparib Veliparib (ABT-888) is an orally bioavailable inhibitor of PARP (Kis: 5.2/2.9 nM for ... Cancer
T2484 AZD2461 AZD2461 is a novel PARP inhibitor. Cancer
T2124 PJ34 hydrochloride PJ34 hydrochloride is a potent specific inhibitor of PARPl/2. Other
T2105 Veliparib dihydrochloride Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.... Other
T1807 JW55 JW 55 is an effective and selective β-catenin signaling pathway inhibitor, works by i... Other
T6339 AG-14361 AG14361 is an effective inhibitor of PARP1 (Ki<5 nM). Cancer